TG Therapeutics, Inc. · 3 days ago
Accounts Payable Specialist
Wonder how qualified you are to the job?
Insider Connection @TG Therapeutics, Inc.
Responsibilities
Responsible for entering and reviewing invoices for accurate recording/coding of information to automated system, ensuring appropriate vendors are paid and payments are made on a timely basis
Support the Controller and Assistant Controller in the day-to-day accounting functions, including Accounts Payable, accrued expenses, and month-end close
Responsible for reviewing and approving monthly expense reports, flagging and reviewing exceptions with compliance & answering expense and payment questions to inquiring employees
Active involvement and support in operational Accounting processes
Account analysis
Proper and timely recording of financial transactions in the general ledger in accordance with GAAP
Preparation and review of journal entries for accruals/reserves, preparation and review of supporting documents
Various administrative duties in support of the Finance team as required
Ad-hoc special projects
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Strong Microsoft Excel and/or Access skills
Strong knowledge of GAAP
Experience with NetSuite or other ERP accounting software systems
Excellent problem solving and analytical skills
Detail-oriented, with excellent organization skills
Excellent oral and written communication skills
Ability to cope in a changing environment
Willingness to learn new tasks
Self-starter with strong organizational and time management skills with ability to multi-task
Preferred
B.A. or B.S. degree in accounting, finance or economics, or related field
Company
TG Therapeutics, Inc.
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases.
Funding
Current Stage
Public CompanyTotal Funding
$205MKey Investors
Hercules Capital
2022-01-04Post Ipo Debt· $70M
2019-12-24Post Ipo Equity· $50M
2019-02-28Post Ipo Debt· $60M
Recent News
2024-06-05
GlobeNewswire
2024-06-05
Company data provided by crunchbase